Acrivon Therapeutics

ACRV · NASDAQ

$1.80+$0.0963 (+5.67%)TodayMarket closed ·
Prev close $1.70

Who owns ACRV

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 59.2% of ACRV’s shares.

  • RA Capital Management, LP28.6%
  • Chione, Ltd.9.0%
  • Sands Capital Ventures LLC5.3%
  • Blume-Jensen (Peter)4.8%
  • Next 6 largest institutions11.5%
  • All other shareholders40.8%
Top institutional holders of ACRV
HolderShares% of shares
RA Capital Management, LP12.23M28.57%
Chione, Ltd.3.85M8.99%
Sands Capital Ventures LLC2.29M5.35%
Blume-Jensen (Peter)2.05M4.79%
Acadian Asset Management LLC1.17M2.72%
Vanguard Capital Management, LLC952.01K2.22%
Wellington Management Company, LLP888.13K2.08%
Renaissance Technologies LLC758.86K1.77%
Two Sigma Investments, LP641.50K1.50%
Marshall Wace LLP531.86K1.24%

Largest mutual fund holders

Top mutual fund holders of ACRV
HolderShares% of shares
Vanguard Total Stock Market Index Fund545.54K1.27%
Vanguard Extended Market Index Fund389.57K0.91%
Bridgeway Ultra-Small Company Fund316.00K0.74%
Fidelity Extended Market Index Fund156.59K0.37%
A4Investments SICAV-SIF Acci Ilana150.00K0.35%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $40.39K (10 trades) of ACRV on the open market, with no buys.

Latest ACRV insider transactions
InsiderTypeSharesValue
Miller MarySale294$585
Levin MichaelaAward130.00K—
Levin MichaelaAward30.00K—
Blume-Jensen PeterSale14.04K$30.97K
Peterson KatharineSale101$203
Miller MarySale185$372
Gamelin ErickSale400$804
Devroe EricSale604$1.21K
Blume-Jensen PeterSale484$973
Blume-Jensen PeterSale1.23K$2.47K

Short interest

Settled Sep 30, 2026

Shares short
1.62M
Days to cover
4.40
% of shares outstanding
3.78%
Average daily volume
367.47K
Change since last report
+34.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.